To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPUSD3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
307 supporting clones for gene RPUSD3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC065741 Bone marrow, acute myelogenous leukemia .a 1 to 1225 2 to 1226 D34H available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1226/1228
(99 %)
5 diff
(99.6 %id)
AK291888 skeletal muscle .a 2 to 1096 1 to 1096 N69K L70P S71Q R72S E73G ... tiling clone,   1096/1096
(100 %)
1 diff
(100.0 %id)
NM_173659.3   .a 2 to 1227 1 to 1226 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1226/1226
(100 %)
0 diff
(100 %id)
BF240771 bone marrow, from acute myelogenous leukemia .a 3 to 612 1 to 634       520/971
(53 %)
39 diff
(96.0 %id)
DA897150 skeletal muscle .a 3 to 548 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DB040447 testis .a 5 to 552 2 to 553   capped   552/552
(100 %)
4 diff
(99.3 %id)
CB960974 Human Placenta, placenta .a 12 to 686 28 to 706       679/788
(86 %)
27 diff
(96.6 %id)
CB959962 Human Placenta, placenta .a 12 to 686 28 to 707       680/767
(88 %)
12 diff
(98.5 %id)
CN430708 embryonic stem cells, DMSO-treated H9 cellline .a 15 to 351 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
DA385081 thalamus .a 16 to 581 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB118559 thymus .a 16 to 577 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BG250121 adenocarcinoma, cell line, Liver .a 17 to 822 1 to 794       794/826
(96 %)
14 diff
(98.4 %id)
BQ068780 brain, neuroblastoma, cell line .a 18 to 597 27 to 617       591/959
(61 %)
24 diff
(97.5 %id)
BU598828 mixed (pool of 40 RNAs) .a 18 to 611 1 to 606       606/826
(73 %)
43 diff
(94.8 %id)
BG714200 brain, hypothalamus .a 20 to 628 1 to 610       610/610
(100 %)
7 diff
(98.9 %id)
BG703287 brain, hippocampus .a 20 to 681 1 to 662       662/662
(100 %)
4 diff
(99.4 %id)
BG719827 testis .a 20 to 761 1 to 743       743/743
(100 %)
8 diff
(99.0 %id)
BG723845 testis .a 20 to 788 6 to 773       768/773
(99 %)
9 diff
(98.9 %id)
BM172224 testis .a 20 to 581 6 to 567       562/567
(99 %)
6 diff
(99.0 %id)
BI460248 testis .a 20 to 540 1 to 520       520/520
(100 %)
4 diff
(99.3 %id)
CR993008 T-Lymphocytes .a 20 to 553 1 to 534       534/535
(99 %)
1 diff
(99.9 %id)
CR995131 T-Lymphocytes .a 20 to 658 1 to 645       645/647
(99 %)
7 diff
(99.0 %id)
CR747537 large cell carcinoma, lung .a 21 to 515 11 to 505       495/505
(98 %)
7 diff
(98.7 %id)
CB116732 Liver .a 21 to 213 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BM746691 Ascites, stomach .a 21 to 539 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BX282009 large cell carcinoma, lung .a 22 to 520 1 to 499       499/500
(99 %)
0 diff
(100 %id)
BI092435 cervix .a 22 to 871 1 to 851       851/888
(95 %)
24 diff
(97.3 %id)
BQ423342 large cell carcinoma, lung .a 23 to 870 1 to 854       854/913
(93 %)
34 diff
(96.3 %id)
BF976410 B-cells, primary B-cells from tonsils (cell line) .a 24 to 729 1 to 716       716/1170
(61 %)
21 diff
(98.3 %id)
BM018167 astrocytoma grade IV, cell line, brain .a 24 to 762 1 to 753       750/754
(99 %)
18 diff
(97.7 %id)
DB487123 hypothalamus .a 25 to 467 1 to 443       443/445
(99 %)
4 diff
(99.2 %id)
DB498428 hypothalamus .a 25 to 552 1 to 528       528/528
(100 %)
3 diff
(99.5 %id)
TI_59388751   .a 25 to 762 114 to 865       749/753
(99 %)
17 diff
(97.8 %id)
BM917145 blood, natural killer cells, cell line .a 26 to 988 1 to 974       972/1106
(87 %)
23 diff
(98.0 %id)
BG474774 eye, retinoblastoma .a 27 to 910 1 to 885       885/889
(99 %)
15 diff
(98.4 %id)
BC032135 Eye, retinoblastoma .a 28 to 1227 1 to 1200   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1200/1200
(100 %)
0 diff
(100 %id)
BX283707 carcinoma, cell line, Prostate .a 28 to 504 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
BP872915 embryonal kidney .a 28 to 505 1 to 478       478/482
(99 %)
3 diff
(99.4 %id)
DT219602 brain .a 30 to 610 1 to 581       581/581
(100 %)
0 diff
(100 %id)
EL735239 mixed .a 30 to 668 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
EL735886 mixed .a 30 to 667 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
BF305646 muscle, rhabdomyosarcoma .a 30 to 697 1 to 663       663/668
(99 %)
7 diff
(99.0 %id)
BQ276431 carcinoma, cell line, Prostate .a 30 to 870 1 to 851       851/974
(87 %)
16 diff
(98.4 %id)
BM844476 myeloma .a 30 to 466 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
BM844505 myeloma .a 30 to 559 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BM785146 myeloma .a 30 to 609 1 to 580       580/580
(100 %)
0 diff
(100 %id)
TI_1948218100   .a 30 to 443 138 to 551   fully sequenced,   414/551
(75 %)
6 diff
(99.0 %id)
TI_1948218268   .a 30 to 443 136 to 549   fully sequenced,   414/549
(75 %)
6 diff
(99.0 %id)
TI_1948218441   .a 30 to 636 136 to 742   fully sequenced,   607/742
(81 %)
7 diff
(99.1 %id)
TI_1948218606   .a 30 to 443 134 to 547   fully sequenced,   414/547
(75 %)
6 diff
(99.0 %id)
TI_1948224477   .a 30 to 726 137 to 835       699/1491
(46 %)
23 diff
(98.5 %id)
TI_1948224478   .a 30 to 613 125 to 711       587/1199
(48 %)
16 diff
(98.7 %id)
TI_1948224785   .a 30 to 520 129 to 621       493/1153
(42 %)
21 diff
(98.2 %id)
TI_1948225111   .a 30 to 724 126 to 822       697/1153
(60 %)
12 diff
(99.0 %id)
TI_1948225431   .a 30 to 613 129 to 713       585/1147
(51 %)
16 diff
(98.7 %id)
BU153212 epithelioid carcinoma, Pancreas .a 31 to 736 1 to 712       712/910
(78 %)
23 diff
(97.5 %id)
BG821158 adenocarcinoma cell line, colon .a 32 to 639 1 to 611       609/611
(99 %)
14 diff
(97.8 %id)
BG769848 melanotic melanoma, high MDR (cell line), skin .a 32 to 821 1 to 792       792/792
(100 %)
2 diff
(99.8 %id)
CR989085 T-Lymphocytes .a 32 to 874 1 to 846       846/913
(92 %)
6 diff
(99.4 %id)
CR985441 T-Lymphocytes .a 34 to 647 1 to 615       615/616
(99 %)
2 diff
(99.7 %id)
DB456876 testis .a 36 to 518 1 to 483       483/491
(98 %)
2 diff
(99.6 %id)
BE780581 eye, retinoblastoma .a 36 to 736 15 to 726       712/779
(91 %)
32 diff
(95.9 %id)
BM564474 blood, natural killer cells, cell line .a 36 to 825 1 to 798   AAA   798/1153
(69 %)
23 diff
(98.1 %id)
BM466468 eye, retinoblastoma .a 36 to 605 25 to 593       569/1018
(55 %)
15 diff
(98.6 %id)
BQ227553 melanotic melanoma, skin .a 36 to 613 1 to 580       580/912
(63 %)
15 diff
(98.4 %id)
BE902748 choriocarcinoma, placenta .a 37 to 853 1 to 815       815/925
(88 %)
22 diff
(97.7 %id)
BM917535 blood, natural killer cells, cell line .a 37 to 658 1 to 621       621/1092
(56 %)
12 diff
(99.0 %id)
BQ053203 blood, natural killer cells, cell line .a 37 to 964 1 to 935       935/1052
(88 %)
15 diff
(98.6 %id)
BQ053405 blood, natural killer cells, cell line .a 37 to 868 1 to 831       831/1064
(78 %)
8 diff
(99.3 %id)
BQ053740 blood, natural killer cells, cell line .a 37 to 871 1 to 840       840/997
(84 %)
12 diff
(98.8 %id)
BQ054022 blood, natural killer cells, cell line .a 37 to 613 1 to 582       582/1276
(45 %)
22 diff
(98.3 %id)
BU553577 ovary, teratocarcinoma, cell line .a 37 to 868 1 to 836       836/889
(94 %)
9 diff
(99.0 %id)
BX364138   .a 38 to 1118 1 to 1074       1074/1124
(95 %)
20 diff
(98.3 %id)
BG740907 skin .a 39 to 874 1 to 835       835/871
(95 %)
3 diff
(99.7 %id)
BE387360 melanotic melanoma, skin .a 42 to 759 28 to 747       720/750
(96 %)
17 diff
(97.8 %id)
CX785931 human embryonic stem cells .a 42 to 773 1 to 732       732/732
(100 %)
0 diff
(100 %id)
DB448146 testis .a 43 to 475 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
CX782342 human embryonic stem cells .a 44 to 760 1 to 717   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 717/717
(100 %)
0 diff
(100 %id)
CN430706 embryonic stem cells, DMSO-treated H9 cellline .a 45 to 721 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
BI253578 cervical carcinoma cell line, cervix .a 45 to 835 1 to 812       810/875
(92 %)
30 diff
(96.6 %id)
AW732437 Kidney, renal cell adenocarcinoma .a 50 to 464 1 to 415       415/415
(100 %)
5 diff
(98.8 %id)
BE264893 lung, small cell carcinoma .a 51 to 569 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BE731957 choriocarcinoma, placenta .a 51 to 841 1 to 791       791/935
(84 %)
19 diff
(98.0 %id)
AA779884   .a 52 to 634 1 to 581     Submitted on the opposite strand 581/581
(100 %)
4 diff
(99.4 %id)
BI821888 pooled brain, lung, testis .a 52 to 1035 1 to 982       982/984
(99 %)
30 diff
(97.0 %id)
TI_57198586   .a 52 to 1035 36 to 1017       982/1019
(96 %)
36 diff
(96.5 %id)
BI826189 brain, medulla .a 53 to 909 1 to 856       856/857
(99 %)
2 diff
(99.8 %id)
TI_57173668   .a 53 to 909 92 to 947       856/948
(90 %)
8 diff
(99.2 %id)
BQ423539 melanotic melanoma, skin .a 54 to 904 1 to 852       853/856
(99 %)
8 diff
(99.1 %id)
BE898022 melanotic melanoma, skin .a 55 to 736 1 to 686       686/753
(91 %)
18 diff
(97.7 %id)
BX333889 Neuroblastoma Cot 50-normalized .a 57 to 1113 1 to 1054       1054/1054
(100 %)
14 diff
(98.7 %id)
BG281111 melanotic melanoma, skin .a 58 to 871 1 to 823       821/881
(93 %)
27 diff
(97.0 %id)
BQ927828 large cell carcinoma, lung .a 59 to 925 54 to 927       874/984
(88 %)
27 diff
(97.3 %id)
BU159486 eye, retinoblastoma .a 69 to 939 1 to 878       878/878
(100 %)
9 diff
(99.0 %id)
BE778459 eye, retinoblastoma .a 72 to 807 1 to 737       736/936
(78 %)
58 diff
(93.9 %id)
BE540622 cervix .a 78 to 672 1 to 598       598/599
(99 %)
9 diff
(98.5 %id)
AW732426 Kidney, renal cell adenocarcinoma .a 107 to 553 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
BE870909 adenocarcinoma, colon .a 110 to 722 1 to 617       617/965
(63 %)
9 diff
(99.1 %id)
CN430707 embryonic stem cells, cell lines H1, H7, andH9 .a 114 to 544 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
TI_1948224787   .a 127 to 1060 1061 to 121       939/1348
(69 %)
29 diff
(97.9 %id)
TI_1948225113   .a 127 to 1060 1064 to 126       939/1326
(70 %)
30 diff
(97.8 %id)
TI_1948224480   .a 199 to 1060 986 to 127       860/1221
(70 %)
13 diff
(99.0 %id)
TI_1948225112   .a 206 to 1060 987 to 126       860/1326
(64 %)
18 diff
(98.7 %id)
BI000765 head_normal .a 234 to 621 392 to 5       388/403
(96 %)
2 diff
(99.6 %id)
CN430709 embryonic stem cells, DMSO-treated H9 cellline .a 255 to 825 1 to 571       571/571
(100 %)
0 diff
(100 %id)
TI_1948225433   .a 275 to 1060 908 to 124       787/1322
(59 %)
3 diff
(99.8 %id)
AW675174 cervical carcinoma cell line, cervix .a 279 to 695 1 to 417       417/418
(99 %)
1 diff
(99.8 %id)
TI_1948225432   .a 307 to 1060 875 to 123       753/1299
(57 %)
27 diff
(98.0 %id)
TI_1948224982   .a 315 to 1060 873 to 128       744/1256
(59 %)
10 diff
(99.3 %id)
TI_1948224479   .a 336 to 1060 850 to 121       728/1402
(51 %)
28 diff
(98.1 %id)
BF915384 uterus_tumor .a 339 to 944 1 to 601       601/608
(98 %)
23 diff
(96.3 %id)
TI_1948225639   .a 342 to 1060 847 to 123       725/1420
(51 %)
13 diff
(99.1 %id)
TI_154127493   .a 349 to 1227 960 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 873/997
(87 %)
6 diff
(99.4 %id)
TI_1948218269   .a 381 to 1060 804 to 124   fully sequenced,   679/802
(84 %)
3 diff
(99.7 %id)
TI_1948218101   .a 382 to 1060 802 to 124   fully sequenced,   679/802
(84 %)
0 diff
(100 %id)
TI_1948218607   .a 382 to 1060 804 to 126   fully sequenced,   679/804
(84 %)
3 diff
(99.7 %id)
AA476962 ovarian tumor, ovary .a 407 to 809 1 to 400       398/400
(99 %)
11 diff
(97.3 %id)
CX758957 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 413 to 1144 1 to 725     Submitted on the opposite strand 725/835
(86 %)
9 diff
(99.0 %id)
TI_1948224786   .a 415 to 1060 779 to 121       659/1434
(45 %)
20 diff
(98.7 %id)
TI_149315987   .a 416 to 1227 889 to 81   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 809/993
(81 %)
9 diff
(99.1 %id)
CA417170 Chondrosarcoma Cell line .a 479 to 1227 767 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 749/749
(100 %)
0 diff
(100 %id)
BF917621 uterus_tumor .a 498 to 849 1 to 352       352/352
(100 %)
7 diff
(98.1 %id)
CB528500 Aveolar Macrophage, lung .a 502 to 1227 743 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 725/733
(98 %)
2 diff
(99.8 %id)
H39593 breast .a 529 to 900 1 to 373   fully sequenced,   373/373
(100 %)
7 diff
(98.2 %id)
BI000076 head_normal .a 534 to 991 26 to 481       456/481
(94 %)
7 diff
(98.6 %id)
BU532740 mixed (pool of 40 RNAs) .a 554 to 1226 1 to 673       673/677
(99 %)
2 diff
(99.8 %id)
CA449035 Chondrosarcoma, Left Pubic Bone .a 560 to 1227 686 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
CB321824 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 570 to 1227 675 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
TI_1948218442   .a 575 to 1060 611 to 126   fully sequenced,   486/611
(79 %)
0 diff
(100 %id)
CB529167 Aveolar Macrophage, lung .a 577 to 1227 668 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 650/650
(100 %)
1 diff
(99.9 %id)
BI489347 brain .a 634 to 1179 555 to 2       554/556
(99 %)
2 diff
(99.7 %id)
TI_45379671   .a 634 to 1179 555 to 2       554/556
(99 %)
2 diff
(99.7 %id)
BE939419 uterus .a 668 to 874 258 to 46       213/258
(82 %)
1 diff
(99.7 %id)
AI125996 uterus .a 674 to 1227 554 to 1       554/554
(100 %)
0 diff
(100 %id)
BF915392 uterus_tumor .a 675 to 1138 474 to 7     Submitted on the opposite strand 468/474
(98 %)
9 diff
(98.2 %id)
BE539139 cervix .a 676 to 1227 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
BF934979 nervous_tumor .a 679 to 910 232 to 1     Submitted on the opposite strand 232/232
(100 %)
14 diff
(94.0 %id)
BU175782 embryonal carcinoma, cell line, testis .a 681 to 1232 228 to 779   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 552/779
(70 %)
6 diff
(99.3 %id)
BF130752 hypernephroma, Kidney .a 685 to 1055 1 to 374       374/374
(100 %)
4 diff
(99.0 %id)
AA703931 bone marrow stroma .a 686 to 1112 426 to 1       426/426
(100 %)
3 diff
(99.3 %id)
CX782266 human embryonic stem cells .a 699 to 1227 556 to 28   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 529/529
(100 %)
1 diff
(99.9 %id)
BE674944 B-cell, chronic lymphotic leukemia .a 706 to 1228 526 to 4       523/526
(99 %)
1 diff
(99.9 %id)
AW131592 brain, medulloblastoma .a 707 to 1228 523 to 2       522/523
(99 %)
0 diff
(100 %id)
EC499384 Prostate .a 720 to 797 11 to 88       78/88
(88 %)
0 diff
(100 %id)
BQ447796 Knee, Osteoarthritic Cartilage .a 727 to 1227 518 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 500/512
(97 %)
4 diff
(99.3 %id)
AI567118 ovary, tumor, 5 pooled (see description) .a 733 to 1228 498 to 3       496/498
(99 %)
0 diff
(100 %id)
BM714437 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 743 to 1227 1 to 485   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
BM716037 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 743 to 1016 1 to 274   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
BG109618 Bone, osteosarcoma, cell line .a 749 to 1227 1 to 478   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
AI682002 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 754 to 1227 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
DB522309 testis .a 762 to 1225 1 to 464     Submitted on the opposite strand 464/466
(99 %)
2 diff
(99.6 %id)
DB526411 testis .a 773 to 1225 1 to 454     Submitted on the opposite strand 454/456
(99 %)
2 diff
(99.6 %id)
AI679084 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 776 to 1227 452 to 1       452/452
(100 %)
0 diff
(100 %id)
DB516973 testis .a 778 to 1227 1 to 450   AAA Submitted on the opposite strand 450/450
(100 %)
4 diff
(99.2 %id)
BE350897 malignant melanoma, metastatic to lymphnode, skin .a 790 to 1228 440 to 2       439/440
(99 %)
0 diff
(100 %id)
DB569517 hypothalamus .a 799 to 1273 1 to 475     Submitted on the opposite strand 475/475
(100 %)
1 diff
(99.8 %id)
AW673005 cervical carcinoma cell line, cervix .a 815 to 1228 416 to 3       414/416
(99 %)
0 diff
(100 %id)
AJ573224 pectoral muscle (after mastectomy) .a 821 to 1228 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
DB556461 hypothalamus .a 845 to 1273 1 to 428     Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
BU752763 placenta .a 865 to 1227 380 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 363/363
(100 %)
0 diff
(100 %id)
H40024 breast .a 868 to 1195 328 to 1   fully sequenced,   328/328
(100 %)
6 diff
(98.2 %id)
F25059 pectoral muscle (after mastectomy) .a 875 to 1216 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
AI572868 lymph node, lymphoma, follicular mixed small and largecell .a 876 to 1227 369 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 352/352
(100 %)
1 diff
(99.8 %id)
AI679655 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 876 to 1227 352 to 1       352/352
(100 %)
0 diff
(100 %id)
BI053229 placenta_normal .a 880 to 1152 277 to 4       274/277
(98 %)
0 diff
(100 %id)
AI937023 anaplastic oligodendroglioma, brain .a 887 to 1227 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AA603003 normal prostate, Prostate .a 894 to 1227 335 to 3       333/335
(99 %)
0 diff
(100 %id)
BF001324 Prostate .a 896 to 1228 333 to 1       333/333
(100 %)
3 diff
(99.1 %id)
BF445750 sympathetic trunk .a 905 to 1227 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
AI205569   .a 946 to 1228 285 to 3       283/285
(99 %)
0 diff
(100 %id)
AA421362   .a 950 to 1217 1 to 266   fully sequenced,   266/266
(100 %)
2 diff
(99.3 %id)
BX328326   .a 960 to 1228 1 to 268       268/268
(100 %)
4 diff
(98.6 %id)
AA991869 germ cell tumor .a 981 to 1227 256 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 246/246
(100 %)
1 diff
(99.6 %id)
BF222892 pooled germ cell tumors .a 982 to 1228 251 to 5       247/251
(98 %)
0 diff
(100 %id)
AI671800 pooled germ cell tumors .a 983 to 1224 249 to 8       242/249
(97 %)
0 diff
(100 %id)
AI953676 pooled germ cell tumors .a 983 to 1228 250 to 5       246/250
(98 %)
0 diff
(100 %id)
BU739781 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 986 to 1224 260 to 22   fully sequenced,   239/260
(91 %)
0 diff
(100 %id)
AW452157   .a 1010 to 1227 235 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 218/218
(100 %)
0 diff
(100 %id)
AI610581 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1017 to 1227 211 to 1       211/211
(100 %)
1 diff
(99.6 %id)
BM675227 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1034 to 1225 211 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 192/192
(100 %)
3 diff
(98.5 %id)
AW138992   .a 1068 to 1227 177 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 160/160
(100 %)
3 diff
(98.2 %id)
AA421264   .a 1086 to 1224 149 to 12   fully sequenced,   138/149
(92 %)
0 diff
(100 %id)
AI922385 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1142 to 1275 141 to 8       134/141
(95 %)
0 diff
(100 %id)
NM_001142547.1   .b 1 to 1181 1 to 1181 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1181/1181
(100 %)
0 diff
(100 %id)
DB461002 testis .b 9 to 490 1 to 481   tiling clone,   481/481
(100 %)
1 diff
(99.8 %id)
BM018964 astrocytoma grade IV, cell line, brain .b 24 to 814 1 to 793       793/795
(99 %)
8 diff
(99.0 %id)
TI_59389641   .b 24 to 814 98 to 890       793/795
(99 %)
8 diff
(99.0 %id)
BC062362 Brain, astrocytoma, grade IV .b 25 to 1181 1 to 1157   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1157/1157
(100 %)
1 diff
(100.0 %id)
BM910853 astrocytoma grade IV, cell line, brain .b 26 to 626 1 to 601       601/1134
(52 %)
14 diff
(98.8 %id)
EL736158 mixed .b 29 to 674 1 to 645       645/648
(99 %)
3 diff
(99.6 %id)
TI_1948224673   .b 29 to 828 132 to 936       805/1382
(58 %)
26 diff
(98.2 %id)
TI_1948224674   .b 29 to 810 129 to 920       792/1162
(68 %)
25 diff
(97.9 %id)
TI_1948224980   .b 29 to 821 125 to 912       788/1384
(56 %)
17 diff
(98.8 %id)
TI_1948224981   .b 29 to 680 127 to 784       658/1235
(53 %)
27 diff
(97.9 %id)
TI_1948225312   .b 29 to 799 121 to 905       785/1176
(66 %)
34 diff
(97.2 %id)
TI_1948225637   .b 29 to 818 124 to 921       798/1479
(53 %)
24 diff
(98.4 %id)
TI_1948225638   .b 29 to 676 127 to 777       651/1216
(53 %)
16 diff
(98.7 %id)
TI_1948224676   .b 126 to 1014 1022 to 128       895/1196
(74 %)
18 diff
(98.5 %id)
TI_1948224983   .b 126 to 1014 1022 to 129       894/1258
(71 %)
26 diff
(98.0 %id)
TI_1948225640   .b 135 to 1014 1006 to 126       882/1271
(69 %)
17 diff
(98.7 %id)
TI_1948224675   .b 141 to 1014 1011 to 125       888/1282
(69 %)
17 diff
(98.7 %id)
TI_1948225314   .b 143 to 1014 1002 to 127       876/1275
(68 %)
21 diff
(98.4 %id)
TI_1948225313   .b 154 to 1014 998 to 122       875/1303
(67 %)
28 diff
(97.9 %id)
BQ059806 lymph, lymphoma, cell line .c 1 to 869 1 to 870 S267A D270T R271G Y272T S273P ... tiling clone,   870/1011
(86 %)
9 diff
(99.2 %id)
BQ065291 lymph, lymphoma, cell line .c 1 to 824 1 to 834   tiling clone,   834/1028
(81 %)
21 diff
(98.0 %id)
BE745283 adenocarcinoma cell line, ovary .d 1 to 691 1 to 689   tiling clone,   689/957
(71 %)
16 diff
(98.4 %id)
BM840333 lymph node, stomach .d 606 to 1144 1 to 540   tiling clone,   540/540
(100 %)
4 diff
(99.3 %id)
BM840252 lymph node, stomach .d 606 to 1098 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
BM845500 lymph node, stomach .d 606 to 1023 1 to 416       416/416
(100 %)
4 diff
(99.1 %id)
BU619698 Cell Line, Chondrosarcoma .d 835 to 1362 546 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 528/528
(100 %)
0 diff
(100 %id)
EC510258 Prostate .d 950 to 1049 1 to 98       98/102
(96 %)
6 diff
(94.2 %id)
BQ223959 melanotic melanoma, skin .e 1 to 907 1 to 910 G209X R210K A234P A254G C263G ... tiling clone,   910/910
(100 %)
15 diff
(98.4 %id)
BQ424997 melanotic melanoma, skin .e 3 to 668 12 to 685   tiling clone,   674/857
(78 %)
30 diff
(96.5 %id)
BJ997242 hepatoblastoma .f 1 to 400 2 to 399   tiling clone,   399/400
(99 %)
5 diff
(98.8 %id)
AL539684 brain, fetal brain .f 6 to 960 1 to 954 W11X R37X S42X L49P K60X ...     954/954
(100 %)
2 diff
(99.8 %id)
BQ059360 lymph, lymphoma, cell line .f 58 to 1000 1 to 951   tiling clone, AAA   951/951
(100 %)
13 diff
(98.7 %id)
BM312443 Pancreas, Purified pancreatic islet .f 590 to 999 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI472634 follicular lymphoma, lymph node .f 737 to 1001 265 to 1   tiling clone,   265/265
(100 %)
0 diff
(100 %id)
AL567997 brain, fetal brain .f 1188 to 2183 995 to 1   tiling clone,   995/995
(100 %)
34 diff
(96.6 %id)
BJ997243 hepatoblastoma .f 1835 to 2191 357 to 1   tiling clone,   357/357
(100 %)
0 diff
(100 %id)
BF972674 leiomyosarcoma cell line, uterus .g 1 to 840 1 to 833 A219T L229A Q230A P231A L232T ... tiling clone,   833/949
(87 %)
21 diff
(97.8 %id)
BQ709020 Spleen .g 14 to 790 1 to 783   tiling clone,   783/953
(82 %)
15 diff
(98.5 %id)
AK296202 thalamus .h 1 to 1547 1 to 1548 R116W tiling clone,   1548/1548
(100 %)
2 diff
(99.9 %id)
CN274520 embryonic stem cells, DMSO-treated H9 cellline .h 658 to 1109 1 to 452       452/452
(100 %)
0 diff
(100 %id)
BM351976 Pancreas, Purified pancreatic islet .h 743 to 1221 479 to 1       479/479
(100 %)
0 diff
(100 %id)
BE350255 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .h 780 to 1222 443 to 1       443/443
(100 %)
0 diff
(100 %id)
BQ877505 epidermoid carcinoma, cell line, salivary gland .i 1 to 960 1 to 968 G152X E182G G183R V184C K185Q ... tiling clone,   968/972
(99 %)
20 diff
(98.0 %id)
BU197244 epidermoid carcinoma, cell line, salivary gland .i 1 to 959 1 to 959 K173R E182G G183R V184C K185Q ... tiling clone,   959/959
(100 %)
28 diff
(97.1 %id)
BQ893034 epidermoid carcinoma, cell line, salivary gland .i 1 to 986 1 to 996 E182G G183S     996/997
(99 %)
40 diff
(96.0 %id)
BQ671242 epidermoid carcinoma, cell line, salivary gland .i 1 to 890 1 to 903 S150F E151*     903/960
(94 %)
25 diff
(97.4 %id)
BM823484 Ascites, stomach .i 471 to 1036 1 to 566   tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
BX361193 Placenta Cot 25-normalized .j 623 to 1088 465 to 1 L187S R188A L189Y Q190N tiling clone,   1094/1125
(97 %)
20 diff
(98.3 %id)
DA200434 brain .k 1 to 577 2 to 579   tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
DN992411 brain, whole brain .k 16 to 400 9 to 393   tiling clone,   385/393
(97 %)
8 diff
(98.0 %id)
DA524224 brain .k 24 to 577 2 to 554   tiling clone, capped   553/553
(100 %)
3 diff
(99.5 %id)
AK093620 thymus .k 157 to 2569 1 to 2413 exact tiling clone, available from FLJ,   2413/2413
(100 %)
5 diff
(99.8 %id)
AX748228   .k 157 to 2569 1 to 2413 exact     2413/2413
(100 %)
5 diff
(99.8 %id)
DB104305 thymus .k 158 to 705 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
CD172269 White Matter .k 685 to 1539 1 to 847       847/847
(100 %)
8 diff
(99.1 %id)
DA862790 placenta .k 1041 to 1599 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
BF841368 head_neck .k 1232 to 1552 11 to 335       325/349
(93 %)
15 diff
(95.8 %id)
DB342728 thymus .k 1975 to 2569 596 to 1       596/596
(100 %)
4 diff
(99.4 %id)
AA707483   .l 1 to 1227 384 to 6       373/398
(93 %)
5 diff
(98.8 %id)
AA776745   .l 1 to 1227 384 to 6       373/409
(91 %)
5 diff
(98.8 %id)
BI549344 brain, hippocampus .l 45 to 993 1 to 960   tiling clone,   960/960
(100 %)
60 diff
(93.8 %id)
TI_44167474   .l 50 to 993 70 to 1024       955/1024
(93 %)
62 diff
(94.0 %id)
AK299556 brain .l 93 to 1358 1 to 1266       1266/1266
(100 %)
3 diff
(99.8 %id)
DA776040 brain .l 94 to 667 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB278204 uterus .l 94 to 645 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
BG709438 brain, hypothalamus .l 99 to 878 1 to 779       779/779
(100 %)
14 diff
(98.3 %id)
BX361194 Placenta Cot 25-normalized .l 106 to 1197 1 to 1083       1083/1093
(99 %)
21 diff
(98.1 %id)
BX366008 Placenta Cot 25-normalized .l 106 to 982 1 to 877       877/877
(100 %)
11 diff
(98.8 %id)
DB500629 hypothalamus .l 107 to 571 1 to 465       465/465
(100 %)
4 diff
(99.2 %id)
DB474230 hippocampus .l 113 to 614 1 to 502       502/503
(99 %)
2 diff
(99.7 %id)
BC049846 Bladder, transitional cell papilloma .l 116 to 1226 1 to 1114   available from MGC, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 1114/1114
(100 %)
7 diff
(99.4 %id)
AK092026   .l 117 to 2583 1 to 2467   tiling clone, available from FLJ,   2467/2467
(100 %)
4 diff
(99.9 %id)
AX747321   .l 117 to 2583 1 to 2467       2467/2467
(100 %)
4 diff
(99.9 %id)
BG285686 bladder, transitional cell papilloma, cell line .l 117 to 839 1 to 720   available from MGC,   720/760
(94 %)
15 diff
(98.1 %id)
DA649747   .l 118 to 652 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
BI116794 lung, small cell carcinoma .l 119 to 773 1 to 665       665/807
(82 %)
30 diff
(96.3 %id)
AL523848 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .l 120 to 1180 1 to 1055   fully sequenced,   1055/1055
(100 %)
24 diff
(97.8 %id)
CR618540 Neuroblastoma Cot 25-normalized .l 121 to 1220 1 to 1100   tiling clone,   1100/1100
(100 %)
0 diff
(100 %id)
N48544 multiple sclerosis lesions .l 121 to 576 1 to 458       458/461
(99 %)
11 diff
(97.7 %id)
BF891884 marrow .l 123 to 646 1 to 527       527/527
(100 %)
15 diff
(97.2 %id)
BF891927 marrow .l 135 to 609 54 to 540       487/540
(90 %)
23 diff
(95.8 %id)
BE257886 eye, retinoblastoma .l 139 to 758 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BE251571 eye, retinoblastoma .l 140 to 827 1 to 719       717/721
(99 %)
57 diff
(92.1 %id)
BG388110 embryonal carcinoma, cell line, testis .l 153 to 652 1 to 499       499/499
(100 %)
3 diff
(99.4 %id)
BM712176 eye, lens .l 195 to 633 1 to 439   fully sequenced,   439/439
(100 %)
0 diff
(100 %id)
BE257885 eye, retinoblastoma .l 214 to 760 83 to 643       530/643
(82 %)
22 diff
(96.6 %id)
AI880284 astrocytoma, brain .l 219 to 720 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
BQ581719 insulinoma, Pancreas .l 314 to 785 1 to 472   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 472/472
(100 %)
4 diff
(99.2 %id)
BU579500 insulinoma, Pancreas .l 314 to 865 1 to 552   fully sequenced, Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 552/552
(100 %)
4 diff
(99.3 %id)
AL523847 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .l 364 to 1203 842 to 1   fully sequenced,   842/842
(100 %)
24 diff
(97.2 %id)
BF891917 marrow .l 419 to 770 352 to 1     Submitted on the opposite strand 352/352
(100 %)
1 diff
(99.8 %id)
CV327420 marrow .l 440 to 770 330 to 1     Submitted on the opposite strand 330/330
(100 %)
9 diff
(97.3 %id)
CV327421 marrow .l 507 to 770 259 to 1     Submitted on the opposite strand 259/275
(94 %)
13 diff
(95.3 %id)
AI870815 anaplastic oligodendroglioma, brain .l 535 to 968 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
BM670238 eye, lens .l 604 to 1226 643 to 21   fully sequenced,   623/643
(96 %)
0 diff
(100 %id)
EL951416 eyeball .l 689 to 1212 1 to 524       524/524
(100 %)
5 diff
(99.1 %id)
DB543038 hippocampus .l 741 to 1226 1 to 486     Submitted on the opposite strand 486/486
(100 %)
2 diff
(99.6 %id)
BQ581463 insulinoma, Pancreas .l 755 to 1228 492 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 474/474
(100 %)
3 diff
(99.4 %id)
DB571801 hypothalamus .l 764 to 1226 1 to 464     Submitted on the opposite strand 464/464
(100 %)
6 diff
(98.8 %id)
AI056506 brain, glioblastoma (pooled) .l 766 to 1227 463 to 2       462/463
(99 %)
0 diff
(100 %id)
BF961784 nervous_normal .l 793 to 1195 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
AA863001 Kidney .l 805 to 1227 422 to 1       422/422
(100 %)
6 diff
(98.6 %id)
AI081492 senescent fibroblast .l 810 to 1227 424 to 7       418/424
(98 %)
0 diff
(100 %id)
BU074234 insulinoma, Pancreas .l 835 to 1228 413 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 394/394
(100 %)
2 diff
(99.5 %id)
AI004349   .l 853 to 1227 380 to 6       375/380
(98 %)
0 diff
(100 %id)
AA570530 Schwannoma tumor .l 920 to 1223 304 to 1       304/304
(100 %)
2 diff
(99.4 %id)
BM352289 Pancreas, Purified pancreatic islet .l 1559 to 2035 1 to 476       476/476
(100 %)
9 diff
(98.2 %id)
CK822338 Pancreas, Purified pancreatic islet .l 1627 to 2167 1 to 541     Submitted on the opposite strand 541/541
(100 %)
0 diff
(100 %id)
BF927579 nervous_tumor .l 1673 to 2117 459 to 17     Submitted on the opposite strand 443/459
(96 %)
0 diff
(100 %id)
BQ347008 nervous_tumor .l 1821 to 2118 312 to 14       299/312
(95 %)
0 diff
(100 %id)
DB321660   .l 2020 to 2583 564 to 1       564/564
(100 %)
0 diff
(100 %id)
DA382763 thalamus .m 1 to 628 2 to 629   tiling clone, capped   628/628
(100 %)
1 diff
(99.9 %id)
DB115011 thymus .m 3 to 559 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA522606 brain .m 13 to 565 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BF733575 amnion_normal .m 195 to 829 5 to 640 P69T V70S T71D G72R P74T ... tiling clone,   636/680
(93 %)
15 diff
(97.8 %id)
AA343373 adrenal gland .m 306 to 555 1 to 251       251/251
(100 %)
2 diff
(99.3 %id)
BG288263 bladder, transitional cell papilloma, cell line .n 1 to 683 1 to 681 R4A R5V V6F L7W G8A ... tiling clone,   681/897
(75 %)
10 diff
(98.9 %id)
BG818025 anaplastic oligodendroglioma with 1p/19qloss, brain .o 1 to 514 1 to 527 R19A P20Q V21C E23R D24T ... tiling clone,   527/798
(66 %)
20 diff
(97.5 %id)
BF736756 bladder_tumor .o 19 to 253 8 to 241   tiling clone,   234/234
(100 %)
7 diff
(97.1 %id)
AI880099 astrocytoma, brain .o 79 to 340 1 to 262   tiling clone, Submitted on the opposite strand 262/262
(100 %)
0 diff
(100 %id)
BE256264 eye, retinoblastoma .p 1 to 548 1 to 551 D20G A68G V69P V70W D71X ... tiling clone,   551/551
(100 %)
3 diff
(99.5 %id)
BE251688 eye, retinoblastoma .p 4 to 635 1 to 629   tiling clone,   629/629
(100 %)
3 diff
(99.6 %id)
Z42221 brain, total brain .p 14 to 221 1 to 207   tiling clone,   207/211
(98 %)
6 diff
(97.2 %id)
F01750 brain, total brain .p 659 to 886 228 to 1   tiling clone,   228/228
(100 %)
2 diff
(99.2 %id)
BG283453 adenocarcinoma, cell line, Prostate .q 1 to 741 1 to 743 A70G tiling clone,   743/743
(100 %)
6 diff
(99.2 %id)
DA014765 adrenal gland .r 1 to 546 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
CX866385 embryonic stem .s 1 to 807 1 to 807 exact tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 807/807
(100 %)
0 diff
(100 %id)
CX866312 embryonic stem .s 1633 to 2165 561 to 29   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 533/533
(100 %)
7 diff
(98.7 %id)
BG335745 choriocarcinoma, placenta .t 1 to 614 5 to 616 F40S V41* tiling clone,   616/888
(69 %)
41 diff
(95.4 %id)
AK094587 amygdala .u-u 1 to 2492 8 to 2499 K54E tiling clone, available from FLJ,   2499/2499
(100 %)
4 diff
(99.9 %id)
DA153048 amygdala .u-u 1 to 566 8 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA415977 thalamus .u-u 83 to 627 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA100864 cerebellum .u-u 126 to 680 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
AW968980   Gene RPUSD3, variant not shown         Suspected internal deletion, this clone was ignored    
BE696654 colon Gene RPUSD3, variant not shown         This clone was ignored    
BM312753 Pancreas, Purified pancreatic islet Gene RPUSD3, variant not shown         This clone was ignored    
AV649584 corresponding non cancerous liver tissue Gene RPUSD3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AA504237 germinal center B cell Gene RPUSD3, variant not shown         Suspected internal deletion, this clone was ignored    
AA806137 epithelium (cell line), Prostate Gene RPUSD3, variant not shown         Suspected internal deletion, this clone was ignored    
AW138386   Gene RPUSD3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG114735 duodenal adenocarcinoma, cell line, small intestine Gene RPUSD3, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB141123 thymus Gene RPUSD3, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_154115368   Gene RPUSD3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C